Zonisamide has beneficial effects on Parkinson's disease patients

被引：114

作者：

Murata, M ^{[1
]}

Horiuchi, E ^{[1
]}

Kanazawa, I ^{[1
]}

机构：

[1] Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan

来源：

NEUROSCIENCE RESEARCH | 2001年 / 41卷 / 04期

关键词：

zonisamide; Parkinson's disease; levodopa; anticonvulsant;

D O I：

10.1016/S0168-0102(01)00298-X

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Zonisamide (ZNS) is a generally well tolerated anticonvulsant that has beneficial effects on Parkinson's disease (PD). ZNS (300 mg/day) given to a patient with PD who incidentally had convulsive attacks, ameliorated the attacks and, surprisingly, his parkinsonian symptoms. We, therefore, carried out an open trial of ZNS on nine patients with PD. Patients were given 50-200 mg/day ZNS in addition to their anti-PD drugs. Seven clearly showed lessening of symptoms, especially wearing-off. We speculate that long lasting activation of dopamine synthesis by ZNS ameliorates parkinsonian symptoms, in particular wearing-off. (C) 2001 Elsevier Science Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

引用

页码：397 / 399

页数：3

共 50 条

[21] Effectiveness of zonisamide in a patient with Parkinson's disease and various levodopa-induced psychotic symptoms [J].

Yabe, Ichiro ;

Ohta, Midori ;

Egashira, Toshiaki ;

Sato, Kazunori ;

Kano, Takahiro ;

Hirotani, Makoto ;

Kunieda, Yasuyuki ;

Sasaki, Hidenao .

NEUROLOGY AND CLINICAL NEUROSCIENCE, 2014, 2 (06) :201-203

[22] Beneficial Effects of Coconut Oil in Treatment of Parkinson’s Disease [J].

K. S. Ibrahim ;

E. M. El-Sayed .

Neurophysiology, 2020, 52 :169-175

[23] Beneficial Effects of Coconut Oil in Treatment of Parkinson's Disease [J].

Ibrahim, K. S. ;

El-Sayed, E. M. .

NEUROPHYSIOLOGY, 2020, 52 (02) :169-175

[24] Repetitive transcranial magnetic stimulation has a beneficial effect on bradykinesia in Parkinson's disease [J].

Siebner, HR ;

Mentschel, C ;

Auer, C ;

Conrad, B .

NEUROREPORT, 1999, 10 (03) :589-594

[25] Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson's Disease [J].

Nishijima, Haruo ;

Miki, Yasuo ;

Ueno, Shinya ;

Tomiyama, Masahiko .

PARKINSONS DISEASE, 2018, 2018

[26] Zonisamide: A review of the clinical and experimental evidence for its use in Parkinson's disease [J].

Grover, Neeta D. ;

Limaye, Ramachandra P. ;

Gokhale, Dilip V. ;

Patil, Tatyasaheb R. .

INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 (06) :547-555

[27] Preliminary study of zonisamide monotherapy in de novo patients with early Parkinson's disease [J].

Ikeda, Ken ;

Sawada, Sayori Hanashiro Masahiro ;

Iwasaki, Yasuo .

NEUROLOGY AND CLINICAL NEUROSCIENCE, 2015, 3 (05) :163-166

[28] Zonisamide Improves Wearing- Off in Parkinson's Disease: A Randomized, Double- Blind Study [J].

Murata, Miho ;

Hasegawa, Kazuko ;

Kanazawa, Ichiro ;

Fukasaka, Junichi ;

Kochi, Kenji ;

Shimazu, Rieko .

MOVEMENT DISORDERS, 2015, 30 (10) :1343-1350

[29] Comparison of zonisamide with non-levodopa, anti-Parkinson's disease drugs in the incidence of Parkinson's disease-relevant symptoms [J].

Iwaki, Hirotaka ;

Tagawa, Masaaki ;

Iwasaki, Kosuke ;

Kawakami, Koji ;

Nomoto, Masahiro .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 402 :145-152

[30] Switch from selegiline to rasagiline is beneficial in patients with Parkinson's disease [J].

Mueller, Thomas ;

Hoffmann, Josef A. ;

Dimpfel, Walter ;

Oehlwein, Christian .

JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (05) :761-765

← 1 2 3 4 5 →